Intralesional injection of Mycobacterium w vaccine vs imiquimod, 5%, cream in patients with anogenital warts a randomized clinical trial

JAMA Dermatology

Volumn 150, Issue 10, 2014, Pages 1072-1078

  Kumar, Pankaj ^a   Dar, Lalit ^a   Saldiwal, Shashi ^a   Varma, Sangeeta ^a   Datt Upadhyay, Aashish ^a   Talwar, Deepti ^a   Sharma, Vinod Kumar ^a   Verma, Kaushal Kumar ^a   Dwivedi, Sada Nand ^a   Raj, Rama ^a   Gupta, Somesh ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; MYCOBACTERIUM VACCINE; AMINOQUINOLINE DERIVATIVE; BACTERIAL VACCINE; IMMUNOLOGICAL ADJUVANT; MYCOBACTERIUM W VACCINE; SKIN CREAM; VIRUS DNA;

ADULT; ARTICLE; BURNING SENSATION; CLINICAL EFFECTIVENESS; CONDYLOMA ACUMINATUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPIGMENTATION; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; EROSION; ERYTHEMA; FEMALE; FOLLOW UP; GENITAL SYSTEM DISEASE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 6; INDIA; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRURITUS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; REMISSION; RISK ASSESSMENT; RISK FACTOR; SKIN EDEMA; SKIN PAIN; SKIN ULCER; UNSPECIFIED SIDE EFFECT; VIRUS IDENTIFICATION; VIRUS LOAD; ADOLESCENT; COMPARATIVE STUDY; CONDYLOMATA ACUMINATA; GENETICS; INTRADERMAL DRUG ADMINISTRATION; INTRALESIONAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; VIROLOGY; YOUNG ADULT;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AMINOQUINOLINES; BACTERIAL VACCINES; CONDYLOMATA ACUMINATA; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 11; HUMANS; INJECTIONS, INTRALESIONAL; MALE; SKIN CREAM; VIRAL LOAD; YOUNG ADULT;

EID: 84908029356     PISSN: 21686068     EISSN: 21686084     Source Type: Journal    
DOI: 10.1001/jamadermatol.2014.794     Document Type: Article

References (22)

1. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342-350.
2. Cox JT, Petry KU, Rylander E, Roy M. Using imiquimod for genital warts in female patients. JWomens Health (Larchmt). 2004;13(3):265-271.
3. Eassa BI, Abou-Bakr AA, El-KhalawanyMA. Intradermal injection of PPD as a novel approach of immunotherapy in anogenital warts in pregnant women. Dermatol Ther. 2011;24(1):137-143.
4. Saini V, Raghuvanshi S, Talwar GP, et al. Polyphasic taxonomic analysis establishes Mycobacterium indicus pranii as a distinct species. PLoS One. 2009;4(7):e6263. doi:10.1371/journal .pone.0006263.
5. Singh IG, Mukherjee R, Talwar GP, Kaufmann SH. In vitro characterization of T cells from Mycobacterium w-vaccinated mice. Infect Immun. 1992;60(1):257-263.
6. Gupta A, Geetha N, Mani J, et al. Immunogenicity and protective efficacy of "Mycobacterium w" against Mycobacterium tuberculosis in mice immunized with live versus heat-killed Mw by the aerosol or parenteral route. Infect Immun. 2009;77(1):223-231.
7. Sharma P, Mukherjee R, Talwar GP, et al. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years. Lepr Rev. 2005;76(2):127-143.
8. Chaudhuri P, Mukhopadhyay S. Bladder preserving approach for muscle invasive bladder cancer - role of Mycobacteriumw. J Indian Med Assoc. 2003;101(9):559-560.
9. Sur PK, Dastidar AG. Role of Mycobacterium was adjuvant treatment of lung cancer (non-small cell lung cancer). J Indian Med Assoc. 2003;101(2):118-120.
10. Ahmad F, Mani J, Kumar P, Haridas S, Upadhyay P, Bhaskar S. Activation of anti-tumor immune response and reduction of regulatory T cells with Mycobacterium indicus pranii (MIP) therapy in tumor bearingmice. PLoS One. 2011;6(9):e25424. doi:10.1371/journal.pone.0025424.
11. Mayosi BM, Ntsekhe M, Bosch J, et al. Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis. Am Heart J. 2013;165(2):109-115, e3. doi:10.1016/j.ahj .2012.08.006.
12. Meena JK, Malhotra AK, Mathur DK, Mathur DC. Intralesional immunotherapy with Mycobacterium w vaccine in patients with multiple cutaneous warts: uncontrolled open study. JAMA Dermatol. 2013;149(2):237-239.
13. Gupta S, Malhotra AK, Verma KK, Sharma VK. Intralesional immunotherapy with killed Mycobacterium w vaccine for the treatment of ano-genital warts: an open label pilot study. J Eur Acad Dermatol Venereol. 2008;22(9):1089-1093.
14. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000;38(1):357-361.
15. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol. 1998;36(10):3020-3027.
16. Lindh M, Görander S, Andersson E, Horal P, Mattsby-Balzer I, Ryd W. Real-time Taqman PCR targeting 14 human papilloma virus types. J Clin Virol. 2007;40(4):321-324.
17. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus - associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006;24(5):736-747.
18. Stone KM. Human papillomavirus infection and genital warts: update on epidemiology and treatment. Clin Infect Dis. 1995;20(suppl 1):S91-S97.
19. Frazer IH, De Kluyver R, Leggatt GR, et al. Tolerance or immunity to a tumor antigen expressed in somatic cells can be determined by systemic proinflammatory signals at the time of first antigen exposure. J Immunol. 2001;167(11): 6180-6187.
20. Beutner KR, Tyring SK, Trofatter KF Jr, et al. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrob Agents Chemother. 1998;42(4):789-794.
21. Perry CM, Lamb HM. Topical imiquimod: a review of its use in genital warts. Drugs. 1999;58 (2):375-390.
22. King M, Johnson SM, Horn TD. Intralesional immunotherapy for genital warts. Arch Dermatol. 2005;141(12):1606-1607.